N/A N=67 Comparing Effectiveness of IV vs Oral Acetaminophen Given Perioperatively for Lap Choles for Pain Control,
Laparoscopic Cholecystectomy
Primary: Pain — 1.41; 1.73; 1.61; 2.32 NRS scale — p=0.875
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=58 Mobility Optimization Through Velocity Exercise
Knee Osteoarthritis
Primary: Change in Basic Lower Limb Function (Late Life Function Index) Late Life Function and Disability Instrument — 3.3; -1.0; 3.1; 0.8 units on a scale
N/A N=113 Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery
Prostate Cancer
Primary: Effect of Green Tea (GT) and Black Tea (BT) Consumption on Percentage of Cells With Positive Staining for Apoptosis, Proliferation, Oxidation, and Inflammation in…
Phase 1 N=40 A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects
Prostate Cancer · Endometriosis
Primary: Cmax: Maximum Observed Plasma Concentration of TAK-385 on Day 1 — 10.9; 20.1 ng/mL
Phase 2 N=10 Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves
Unilateral Carpal Tunnel Syndrome
Primary: Implant Success — 10 participants with successful implant
N/A N=164 Smoking Cessation Via Text Messaging: Feasibility Testing of Stop My Smoking USA
Smoking Cessation
Primary: Continuous Abstinence at 3-months Assessed in Accordance With the NIH Behavior Change Consortium's Recommendations — 40; 19 participants
N/A N=30 Microcurrent for Healing Autogenous Skin Donor Sites
Burns
Primary: Time to Wound Healing — 10.8; 11.1 days
N/A N=57 Study of the Preservation of the Left Colic Artery on Rectum Cancer Surgery
Rectum Cancer
Primary: The Blood Pressure of the Arterial Arcade — 42.31; 48.50 mmHg
Phase 2 N=20 Pilot Study to Evaluate The Effectiveness And Safety Of Axiom Worldwide Drx9000™ Spinal Decompression System
Low Back Pain
Primary: Post-treatment Numerical Pain Intensity Rating Scale (VRS), Which is a Scale From 0-10 (0=no Pain, 10= Worst Pain) — 0 units on a scale — p=.0001
Phase 3 N=315 A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Eosinophilic Asthma
Primary: Change From Baseline In Forced Expiratory Volume In 1 Second (FEV1) Over 16 Weeks Using Mixed Model for Repeated Measures — 0.126; 0.242; 0.286 liters — p=0.0018
Phase 2 N=3 Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant
Stage I Multiple Myeloma · Stage II Multiple Myeloma · Stage III Multiple Myeloma
Primary: Proportion of Patients Experiencing a Stringent Complete Response (sCR) After 12 Cycles, 24 Months — 100; 0; 100 percentage of participants
Phase 3 N=54 Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae
End Stage Renal Disease · AV Fistula · Kidney Failure
Primary: Use of Venous Window Needle Guide to Obtain Arteriovenous Access for Hemodialysis — 49 participants
Phase 2 N=97 Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer
Ovarian Neoplasms
Primary: Progression Free Survival (PFS) — 19; 20; 20 Participants — p=0.6604
Phase 3 N=460 Establishing the Vitamin D Requirements During Lactation
Vitamin D Deficiency
Primary: 25-Hydroxyvitamin D Levels for Postpartum Mother 7 Months After Delivery — 28.5; 38.0; 55.6 ng/mL
Phase 3 N=835 The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
Diabetes · Diabetes Mellitus, Type 1
Primary: Change From Baseline in Glycosylated Haemoglobin (HbA1c) — -0.23; -0.23; -0.32; 0.01 Percent (%) glycosylated haemoglobin — p=< 0.0001